Erratum: Aberrant Expression miR-196a is Associated with Abnormal Apoptosis, Invasion, and Proliferation of Pancreatic Cancer Cells (Pancreas. (2013) 42 (1169-1181) DOI: 10.1097/MPA.0b013e3182962acb);Aberrant expression mir-196a is associated with abnormal apoptosis, invasion, and proliferation of pancreatic cancer cells

Pancreas

Volumn 42, Issue 7, 2013, Pages 1169-1181

  Liu, Minghao ^a   Du, Yiqi ^a   Gao, Jun ^a   Liu, Jianqiang ^a   Kong, Xiangyu ^a   Gong, Yanfang ^a   Li, Zhaoshen ^a   Wu, Hongyu ^a   Chen, Hui ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

ING5; microRNA; miR 196a; pancreatic cancer

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; GROWTH INHIBITOR; INHIBITOR OF GROWTH 5; MICRORNA; MICRORNA 196A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR INVASION; TUMOR VOLUME;

3' UNTRANSLATED REGIONS; ADENOCARCINOMA; ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; HETEROGRAFTS; HUMANS; MICE; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84885100065     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000001515     Document Type: Erratum

References (36)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10-29.
2. Gunduz M, Gunduz E, Rivera RS, et al. The inhibitor of growth (ING) gene family: potential role in cancer therapy. Curr Cancer Drug Targets. 2008;8(4):275-284. (Pubitemid 351881353)
3. Russell M, Berardi P, GongW, et al. Grow-ING, Age-ING and Die-ING: ING proteins link cancer, senescence and apoptosis. Exp Cell Res. 2006;312(7):951-961.
4. Soliman MA, Riabowol K. After a decade of study-ING, a PHD for a versatile family of proteins. Trends Biochem Sci. 2007;32(11):509-519. (Pubitemid 350008066)
5. Coles AH, Jones SN. The ING gene family in the regulation of cell growth and tumorigenesis. J Cell Physiol. 2009;218(1):45-57.
6. Unoki M, Kumamoto K, Takenoshita S, et al. Reviewing the current classification of inhibitor of growth family proteins. Cancer Sci. 2009;100(7):1173-1179.
7. Ambros V. The functions of animal microRNAs. Nature. 2004; 431(7006):350-355. (Pubitemid 39265675)
8. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281-297.
9. Lai EC. Micro RNAs are complementary to 3¶ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet. 2002;30(4):363-364.
10. Xie X, Lu J, Kulbokas EJ, et al. Systematic discovery of regulatory motifs in human promoters and 3¶ UTRs by comparison of several mammals. Nature. 2005.434(7031):338-345. (Pubitemid 40469170)
11. Kim YJ, Bae SW, Yu SS, et al. MiR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue. J Bone Miner Res. 2009;24(5):816-825.
12. Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007;297(17):1901-1908. (Pubitemid 46707844)
13. Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science. 2004;304(5670):594-596. (Pubitemid 38541919)
14. Hornstein E., Mansfield JH, Yekta S, et al. The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development. Nature. 2005;438(7068):671-674. (Pubitemid 41740577)
15. Kong X, Du Y, Wang G, et al. Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Dig Dis Sci. 2010;56:602-609.
16. Kutner RH, Zhang XY, Reiser J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc. 2009;4(4): 495-505.
17. Zhang Y, Li M, Wang H, et al. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg. 2009;33(4):698-709.
18. Liu B, Wang K, Gao HM, et al. Molecular consequences of activated microglia in the brain: overactivation induces apoptosis. J Neurochem. 2001;77(1):182-189. (Pubitemid 32245092)
19. Bockhorn M, Jain RK, Munn LL. Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed? Lancet Oncol. 2007;8(5):444-448. (Pubitemid 46621773)
20. Gallagher SF, Zervos EE, Murr MM. Distal pancreatectomy. In: von Hoff DD, Evans DB, Hruban RH, eds. Pancreatic Cancer. Boston, MA: Jones and Bartlett Publishing Company; 2005:299-312.
21. Yen TW, Abdalla EK, Pisters PW, et al. Pancreaticoduodenectomy. In: von Hoff DD, Evans DB, Hruban RH, eds. Pancreatic Cancer. Boston, MA: Jones and Bartlett Publishing Company; 2005:265-286.
22. Bilimoria KY, Bentrem DJ, Ko CY, et al. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer. 2007;110:738-744. (Pubitemid 47257648)
23. Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg. 1999;189:1-7. (Pubitemid 29307735)
24. Szafranska AE, Doleshal M, Edmunds HS, et al. Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin Chem. 2008;54(10):1716-1724.
25. Schimanski CC, Frerichs K, Rahman F, et al. High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J Gastroenterol. 2009;15(17):2089-2096.
26. Zhang L, Zhang Y,Wang H, et al. MicroRNA-196a enhances pancreatic cancer cell proliferation and invasion in vitro and promotes tumor growth and metastasis in xenotransplanted mice. J Surg Res. 2011; 165(2):261.
27. Wynter CV. The dialectics of cancer: a theory of the initiation and development of cancer through errors in RNAi. Med Hypotheses. 2006;66(3):612-635. (Pubitemid 43060182)
28. De Martino I, Visone R, Fedele M, et al. Regulation of microRNA expression by HMGA1 proteins. Oncogene. 2009;28(11):1432-1442.
29. Luthra R, Singh RR, Luthra MG, et al. MiR-196a-oncogene 2008 MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene. 2008;27:6667-6678.
30. Coskun E, von der Heide EK, Schlee C, et al. The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia. Leuk Res. 2011;35(2):208-213.
31. Xing Y, Yang X, Xu X, et al. The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression. Hum Pathol. 2011;42(1):25-35.
32. Li X, Nishida T, Noguchi A, et al. Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma. J Cancer Res Clin Oncol. 2010;136(10):1573-1583.
33. Cengiz B, Gunduz E, Gunduz M, et al. Tumor-specific mutation and downregulation of ING5 detected in oral squamous cell carcinoma. Int J Cancer. 2010;127(9):2088-2094.
34. Zheng H, Xia P, Xu X, et al. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas. Hum Pathol. 2011;42(3):424-433.
35. Morton JP, Timpson P, Karim SA, et al. Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc Natl Acad Sci U S A. 2010;107(1):246-251.
36. Bergan A, Gladhaug IP, Schjolberg A, et al. P53 accumulation confers prognostic information in resectable adenocarcinomas with ductal but not with intestinal differentiation in the pancreatic head. Int J Oncol. 2000;17(5):921-926.